Australia markets closed

ALR Technologies Inc. (ALRTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0210+0.0010 (+5.00%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0200
Open0.0210
BidN/A x N/A
AskN/A x N/A
Day's range0.0210 - 0.0210
52-week range0.0113 - 0.0499
Volume111
Avg. volume29,565
Market cap12.526M
Beta (5Y monthly)0.28
PE ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study

    ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titled Method and System of Monitoring a Diabetes Treatment Plan ("Predictive A1c") has been granted in Singapore and has received notice of allowance in the United States.

  • GlobeNewswire

    ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM

    SINGAPORE, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT” or the “Company”) (OTCQB:ALRTF), the diabetes management company, announces plans to launch the GluCurve Pet CGM (“GluCurve”) in Canada during Q3 2023 with a direct to veterinarian clinic sales model through GluCurve.ca. The Canadian website will go live on or before August 28th when the Company expects to begin taking orders. The inventory from the purchase order announced on June 1, 2023 will now be used for the Cana

  • GlobeNewswire

    ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs

    SINGAPORE, June 01, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT”) (OTCQB:ALRTF), the diabetes management company, announces the issuance of a purchase order for the first shipment of second generation CGM hardware used in the GluCurve Pet CGM. The shipment is expected to be delivered to ALRT’s distributor in early Q3 with a sales value of USD $350,000. “We quickly sold out of inventory during our soft launch in January due to tremendous interest in the GluCurve Pet CGM from veterina